Revance Therapeutics, Inc. (39) | License Agreements (3)
Recent Contracts
-
Second Addendum to License and Service Agreement, dated March 2, 2021 between Revance Therapeutics, Inc. and List Biological Laboratories, Inc
(Filed With SEC on May 10, 2021)
-
Letter Amendment to the License Agreement dated January 8, 2020 by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd
(Filed With SEC on February 25, 2021)
-
License Agreement, dated December 4, 2018, by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd
(Filed With SEC on February 28, 2019)
